C21 Investments Q1 Loss Widens; Going Concern Risk Disclosed as Vireo Acquisition Nears Close
CXXIF sits 58% above its 52-week low of $0.168 on elevated volume (3.4× avg).
Summary
C21 Investments reported a wider Q1 loss and disclosed going concern risk, while confirming the Vireo Growth acquisition is expected to close today.
Key Events · Earnings and Guidance · CXXIF
-
Q1 Net Loss Widens
Net loss was $1.97 million for the three months ended June 30, 2026, versus $0.76 million in the prior-year quarter.
-
Revenue Declines 10.8%
Revenue fell to $7.63 million from $8.55 million, driven by price compression and increased competition in Nevada.
-
Going Concern Risk Disclosed
The company states that changes in federal enforcement priorities could impact its ability to continue as a going concern.
-
Uncertain Tax Position Increases
Uncertain tax position rose to $14.09 million from $13.36 million at March 31, 2026, related to Section 280E.
Analysis · CXXIF · Life Sciences
C21 Investments reported a net loss of $1.97 million for the quarter ended June 30, 2026, compared to a loss of $0.76 million a year earlier, as revenue fell 10.8% to $7.63 million. The company also disclosed going concern language related to federal cannabis enforcement uncertainty and an increased uncertain tax position of $14.09 million. The filing confirms the Vireo Growth acquisition is expected to close on August 21, 2026, which is today's date.
At the time of this filing, CXXIF was trading at $0.26 on OTC in the Life Sciences sector, with a market capitalization of approximately $57.9M. The 52-week trading range was $0.17 to $0.54. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.